Surgical Oncology and General Surgery Department, King Khaled Hospital, Najran, Saudi Arabia.
Surgical Oncology and General Surgery Department, King Khaled Hospital, Najran, Saudi Arabia.
Surg Oncol. 2022 Aug;43:101775. doi: 10.1016/j.suronc.2022.101775. Epub 2022 Apr 21.
Peritoneal metastasis (PM) of colorectal cancer (CRC) origin can be treated and cured. This article presents a practical guide for CRC surgeons facing a patient with PM and presents the different options of treatment at expert centers on peritoneal surface malignancies. The unexpected finding of PM could be overwhelming, especially during an emergency CRC surgery. Clear indications on managing these situations call for clarification to avoid any negative impact on the oncologic outcome of patients with CRC. All patients with PM of CRC origin must be evaluated by a tumor board or multidisciplinary team specialized in the management of peritoneal surface malignancies since currently there are available options of treatment for patients with resectable peritoneal disease, unresectable peritoneal disease, and even patients with synchronous liver metastases (LM) could benefit from a multimodal approach.
结直肠癌腹膜转移(PM)是可以治疗和治愈的。本文为面对结直肠癌腹膜转移患者的结直肠外科医生提供了实用指南,并介绍了腹膜表面恶性肿瘤治疗的不同选择。在紧急结直肠癌手术期间,PM 的意外发现可能会令人不知所措。明确处理这些情况的指征需要加以澄清,以避免对结直肠癌患者的肿瘤学结果产生任何负面影响。所有结直肠癌腹膜转移患者都必须由专门从事腹膜表面恶性肿瘤治疗的肿瘤委员会或多学科团队进行评估,因为目前对于可切除腹膜疾病、不可切除腹膜疾病的患者都有可用的治疗方案,甚至对于同步肝转移(LM)的患者,也可以从多模式治疗中获益。